MicroRNA signatures associated with radioiodine refractoriness and tumor dedifferentiation in metastatic papillary thyroid carcinoma.

Endocrine · 2026 · PMC12971732 · PMID 41801518

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the univariate analysis (Mann-Whitney U test), miR-200c-3p was significantly down expressed in patients with radioiodine-refractory disease ( P = 0.003), while miR-21-5p ( P = 0.083) and miR-31-5p ( P = 0.093) showed a trend toward higher expression in this group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.